Earnest Partners LLC Buys 206,278 Shares of Synopsys, Inc. $SNPS

Earnest Partners LLC boosted its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 68.6% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 507,136 shares of the semiconductor company’s stock after buying an additional 206,278 shares during the period. Synopsys makes up 1.1% of Earnest Partners LLC’s portfolio, making the stock its 19th largest holding. Earnest Partners LLC owned 0.27% of Synopsys worth $250,216,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Alpine Bank Wealth Management boosted its holdings in shares of Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 25 shares during the period. TFC Financial Management Inc. increased its stake in shares of Synopsys by 1,250.0% during the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the period. Millstone Evans Group LLC acquired a new stake in Synopsys during the 3rd quarter worth approximately $27,000. SOA Wealth Advisors LLC. bought a new stake in Synopsys in the 3rd quarter valued at $28,000. Finally, McIlrath & Eck LLC bought a new stake in Synopsys in the 3rd quarter valued at $29,000. 85.47% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on SNPS shares. KeyCorp increased their price objective on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Wells Fargo & Company decreased their price target on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 26th. The Goldman Sachs Group set a $600.00 price target on shares of Synopsys and gave the stock a “buy” rating in a research report on Wednesday, February 25th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Finally, Needham & Company LLC reissued a “buy” rating on shares of Synopsys in a report on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $531.00.

Read Our Latest Stock Report on SNPS

Insider Activity

In other news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 4,157 shares of company stock worth $1,945,036. Insiders own 0.56% of the company’s stock.

Synopsys Stock Performance

NASDAQ:SNPS opened at $412.63 on Friday. The stock has a fifty day moving average price of $461.93 and a 200-day moving average price of $463.65. The company has a market cap of $79.04 billion, a price-to-earnings ratio of 64.07, a PEG ratio of 3.36 and a beta of 1.15. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.26 and a current ratio of 1.36. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The company had revenue of $2.41 billion for the quarter, compared to analysts’ expectations of $2.39 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.Synopsys’s revenue was up 65.6% on a year-over-year basis. During the same quarter last year, the business earned $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. As a group, equities analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.